Walgreens rolls out gene, cell therapy services

Walgreens is expanding its specialty pharmacy offerings, including gene and cell therapy services, the company said April 25. 

Advertisement

The rebranded business, Walgreens Specialty Pharmacy, includes an 18,000-square-foot facility in Pittsburgh, four central specialty pharmacies and nearly 300 community specialty pharmacies, according to a news release. The company also has 1,500 specialty-trained pharmacists, 5,000 patient advocacy support team members and 240 limited distribution drugs. 

On Aug. 1, AllianceRx Walgreens, a specialty and home delivery segment, will become Walgreens Specialty Pharmacy. 

The company said the decision to combine specialty services with new gene and cell therapy offerings is to have a larger role in the growing market. Specialty medications account for more than 50% of prescription drug spend in the U.S., the release said. 

Walgreens added it is the largest provider “not vertically aligned with a pharmacy benefit manager” — unlike CVS Health.

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

The Performance Gap Your Pharmacy Training Metrics Can’t See

Monday, August 10
12:00 PM - 1:00 PM CDT

Presenters: Michael Alexander, AudirieDr. Tina Moen, PharmD, Colibri Healthcare

Advertisement

Next Up in Pharmacy

Advertisement

Comments are closed.